Table 1 Characteristics of study populations
Characteristics | Pre-intervention (n = 1097) | Post-intervention (n = 817) | p value |
|---|---|---|---|
Age, mean (SD) | 55 (18.5) | 52 (18.8) | 0.020* |
Gender, n (%) | |||
Male | 638 (58.2) | 462 (56.5) | 0.481 |
Female | 459 (41.8) | 355 (43.5) | |
Comorbidities, n (%) | |||
Cardiovascular | 619 (56.4) | 454 (55.6) | 0.709 |
Endocrine | 405 (36.9) | 261 (31.9) | 0.024 |
Renal | 396 (36.1) | 274 (33.5) | 0.245 |
Respiratory | 214 (19.5) | 151 (18.5) | 0.572 |
Neurological | 80 (7.3) | 52 (6.4) | 0.428 |
Rheumatological | 78 (7.1) | 66 (8.1) | 0.427 |
Infection | 48 (4.4) | 20 (2.4) | 0.024 |
Urological | 37 (3.4) | 16 (2.0) | 0.062 |
Psychiatric illnesses | 29 (2.6) | 13 (1.6) | 0.120 |
Malignancy | 21 (1.9) | 13 (1.6) | 0.597 |
Hematological | 10 (0.9) | 11 (1.3) | 0.366 |
Gastrointestinal | 8 (0.7) | 7 (0.9) | 0.754 |
Others | 10 (0.9) | 9 (1.1) | 0.678 |
Nil | 54 (4.9) | 63 (7.7) | 0.012 |
Number of medications per prescription, mean (SD) | 6.8 (3.9) | 6.7 (3.9) | 0.879* |
Dispensing location, n (%) | |||
Bedside | 450 (41) | 445 (54.5) | < 0.001 |
Counter | 647 (59) | 372 (45.5) |